Genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces it has completed the assay design for the Company’s Point-of-Care (“POC”) solution for COVID-19 testing and is now generating
Genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces it has completed the assay design for the Company’s Point-of-Care (“POC”) solution for COVID-19 testing and is now generating
Genedrive® 96 SARS-CoV-2 Kit verified with Beckman Coulter Life Sciences RNA extraction chemistry
Further evidence for the use of the EarlyCDT Lung blood test in lung cancer screening
Beckman Coulter collaboration to automate high throughput SARS-CoV-2 PCR testing
Share Talk caught up with Manchester-based company Genedrive PLC and spoke with David Budd, CEO about the company recent announcement with the development of two coronavirus tests, one for central
Oil has been trading like a penny share, bagging at one point earlier in the week. For the first time ever, the price even went negative for delivery. It’s being